Get the Stockscreener App
192.97
0.64%
1.22
After Hours:
193.87
0.90
+0.47%
Overview
News
Price History
Option Chain
Financials
Why ABBV Down?
Discussions
Forecast
Dividend History
Abbvie Inc Stock (ABBV) Latest News
Earnings Season Scorecard and Fresh Research Reports for Walmart, Visa & AbbVie - Yahoo Finance
3 Top AI-Powered Biotech Stocks to Buy in February - The Motley Fool
Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign - AbbVie
Brandywine Oak Private Wealth LLC Sells 1,465 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Tyche Wealth Partners LLC - MarketBeat
AbbVie secures $3 billion credit facility, total access now $8 billion - Investing.com
Medicare Part D Redesign: More Firms See New Discounts Offsetting Spending Cap Benefit - Citeline News & Insights
Abbvie Entered Revolving Credit Facility Up To $3 Billion Maturing In 2030 -February 05, 2025 at 04:24 pm EST - Marketscreener.com
Jim Cramer Says AbbVie Inc. (ABBV) Is A ‘Buy’ - Insider Monkey
AbbVie Rises 8% Since Q4 Earnings: Buy, Hold Or Sell The Stock? - Barchart
AbbVie Rises 8% Since Q4 Earnings: Buy, Hold or Sell the Stock? - Yahoo Finance
AbbVie Inc. (NYSE:ABBV) Position Boosted by Tectonic Advisors LLC - MarketBeat
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase - Benzinga
Mirae Asset Global Investments Co. Ltd. Buys 149,048 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Sargent Investment Group LLC Sells 10,876 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Is Wall Street Bullish or Bearish on AbbVie Stock? - Nasdaq
Is Wall Street Bullish Or Bearish On AbbVie Stock? - Barchart
Concord Asset Management LLC VA Acquires 1,550 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie (NYSE:ABBV) Trading Down 0.1%What's Next? - MarketBeat
Analysts reset AbbVie stock price target after earnings - TheStreet
AbbVie Inc. (NYSE:ABBV) is Welch Group LLC's 9th Largest Position - MarketBeat
Daiwa Securities Adjusts Price Target on AbbVie to $190 From $180, Keeps Neutral Rating - Marketscreener.com
Rockline Wealth Management LLC Has $5.69 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Cullinan Associates Inc. Decreases Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Columbus Macro LLC Buys 29,524 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
abrdn plc Cuts Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value - GuruFocus.com
AbbVie Inc. (NYSE:ABBV) Shares Bought by Waldron Private Wealth LLC - MarketBeat
AbbVie's SWOT analysis: stock outlook strong despite humira loss - MSN
Independence Bank of Kentucky Increases Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Chicago Partners Investment Group LLC Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
China Universal Asset Management Co. Ltd. Grows Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Stock Soars as Biotech Tops Sales Estimates, Raises Outlook - MSN
Healthcare Powerhouses Join TriSalus Board: Ex-Fresenius CEO and AbbVie Oncology Pioneer Unite - StockTitan
AbbVie Target of Unusually Large Options Trading (NYSE:ABBV) - MarketBeat
AbbVie (NYSE:ABBV) Price Target Raised to $215.00 - MarketBeat
AbbVie (NYSE:ABBV) Price Target Raised to $217.00 - MarketBeat
Looking At AbbVie's Recent Unusual Options Activity - Benzinga
Nike To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today’s Top S&P 500 Performers. - MSN
UBS Group Increases AbbVie (NYSE:ABBV) Price Target to $190.00 - MarketBeat
AbbVie (NYSE:ABBV) Shares Up 2.6% on Analyst Upgrade - MarketBeat
AbbVie (NYSE:ABBV) Price Target Raised to $210.00 at Wells Fargo & Company - MarketBeat
AbbVie (NYSE:ABBV) Price Target Raised to $239.00 at Morgan Stanley - MarketBeat
UBS Adjusts Price Target on AbbVie to $190 From $181, Maintains Neutral Rating -February 03, 2025 at 09:40 am EST - Marketscreener.com
Hodges Capital Management Inc. Acquires 5,587 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Guggenheim Increases AbbVie (NYSE:ABBV) Price Target to $214.00 - MarketBeat
AbbVie (NYSE:ABBV) Earns "Outperform" Rating from Raymond James - MarketBeat
Jennison Associates LLC Sells 857,207 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie (NYSE:ABBV) Price Target Raised to $215.00 at BMO Capital Markets - MarketBeat
Lederer & Associates Investment Counsel CA Purchases Shares of 10,321 AbbVie Inc. (NYSE:ABBV) - MarketBeat
Deutsche Bank Adjusts AbbVie Price Target to $173 From $177, Maintains Hold Rating - Marketscreener.com
AbbVie Inc. (NYSE:ABBV) Q4 2024 Earnings Call Transcript - MSN
Leerink Adjusts Price Target on AbbVie to $210 From $206, Maintains Outperform Rating - Marketscreener.com
HHM Wealth Advisors LLC Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Goldman Sachs Adjusts Price Target on AbbVie to $212 From $208, Keeps Buy Rating - Marketscreener.com
Wolfe Research Adjusts Price Target on AbbVie to $220 From $205, Keeps Outperform Rating - Marketscreener.com
Stock Yards Bank & Trust Co. Cuts Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by Spire Wealth Management - MarketBeat
Abbvie (ABBV) PT Raised to $212 at Goldman Sachs - StreetInsider.com
Why AbbVie Inc. (ABBV) Is Among the Best Cancer Stocks to Buy According to Hedge Funds - MSN
10 Best Cancer Stocks to Buy According to Hedge Funds - Insider Monkey
CENTRAL TRUST Co Grows Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Citadel Investment Advisory Inc. Raises Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Can AbbVie Inc.'s (NYSE:ABBV) ROE Continue To Surpass The Industry Average? - Yahoo Finance
AbbVie Inc. (NYSE:ABBV) Shares Purchased by U.S. Capital Wealth Advisors LLC - MarketBeat
Greenleaf Trust Purchases 5,991 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Golden State Equity Partners Boosts Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Journey Strategic Wealth LLC Has $1.73 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Sylvest Advisors LLC Takes $1.14 Million Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
DAVENPORT & Co LLC Acquires 1,759 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
0.76%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):